Specifically, KSR2 regulates endothelial glycolytic balance through activation of the AMPK signaling pathway, thereby inhibiting endothelial inflammation and apoptosis, which ultimately slows the progression of atherosclerosis. Here, PRKAA1 is linked to atherosclerosis.